• DOI:10.1111/j.1749-6632.1995.tb31386.x
Corpus ID: 36861309

Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity

@article{Muhn1995DrospirenoneAN,
  title={Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity},
  author={Peter Muhn and U. Fuhrmann and K. Fritzemeier and R. Krattenmacher and E. Schillinger},
  journal={Annals of the New York Academy of Sciences},
  year={1995},
  volume={761}
}

Peter Muhn, U. Fuhrmann, +2 authors E. Schillinger

Published 1995

Chemistry, Medicine

Annals of the New York Academy of Sciences

Drospirenone (ZK 30595; 6 beta, 7 beta, 15 beta, 16 beta-dimethylen-3-oxo-17 alpha-pregn-4-ene-21, 17-carbolactone) is a novel progestogen under clinical development. Drospirenone is characterized by an innovative pharmacodynamic profile which is very closely related to that of progesterone. Potential applications include oral contraception, hormone replacement therapy and treatment of hormonal disorders. The pharmacological properties of drospirenone were investigated in vitro by receptor… CONTINUE READING

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed